PUBLISHER: The Business Research Company | PRODUCT CODE: 1948614
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948614
Vascular stents are intricately designed metal mesh tubes utilized in medical procedures to prevent vessel closure and enhance blood flow in narrowed or blocked veins and arteries. This intervention, commonly referred to as 'vascular stenting,' aims to minimize the risk of late restenosis while supporting swift recovery by widening obstructed arteries, thus reducing the likelihood of infections and physical complications.
The primary categories of vascular stent products include coronary stents, peripheral vascular stents, and EVAR stent grafts. Coronary stents specifically target constricted arteries supplying oxygenated blood to the heart, playing a crucial role in maintaining arterial patency post-angioplasty. Within the vascular stent market, these stents encompass various types such as bare metal stents, bio-engineered and bioresorbable vascular scaffolds, drug-eluting stents, and dual therapy stents. These stents are crafted from materials like cobalt-chromium, platinum-chromium, nickel titanium, stainless steel, and polymers. Their deployment methods involve balloon-expandable and self-expanding stents, utilized across ambulatory surgical centers, cardiac facilities, and hospitals.
Tariffs are influencing the vascular stent market by increasing costs of imported cobalt-chromium alloys, nitinol materials, polymers, precision manufacturing equipment, and sterilization technologies. Cardiac centers and hospitals in North America and Europe are most affected due to reliance on imported high-precision stents, while Asia-Pacific faces higher export manufacturing costs. These tariffs are increasing device prices and procurement costs. However, they are also encouraging localized stent manufacturing, regional material sourcing, and innovation in cost-efficient stent designs.
The vascular stent market research report is one of a series of new reports from The Business Research Company that provides vascular stent market statistics, including vascular stent industry global market size, regional shares, competitors with a vascular stent market share, detailed vascular stent market segments, market trends and opportunities, and any further data you may need to thrive in the vascular stent industry. This vascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vascular stent market size has grown rapidly in recent years. It will grow from $17.25 billion in 2025 to $19.11 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, expansion of catheterization laboratories, rising adoption of angioplasty procedures, growth in aging population, improved access to interventional cardiology.
The vascular stent market size is expected to see rapid growth in the next few years. It will grow to $28.21 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing demand for next-generation stent technologies, rising focus on personalized cardiovascular treatments, expansion of minimally invasive cardiac care, growing investments in advanced biomaterials, increasing adoption of digital imaging-guided interventions. Major trends in the forecast period include increasing adoption of drug-eluting and bioresorbable stents, rising demand for minimally invasive vascular procedures, growing use of advanced alloy and polymer materials, expansion of peripheral vascular interventions, enhanced focus on long-term restenosis prevention.
The rise in healthcare expenditure is anticipated to boost the growth of the vascular stent market. Healthcare expenditure refers to the total resources allocated, typically measured in monetary terms, by a country, organization, or individual for healthcare-related goods and services over a specific period. Higher healthcare spending leads to better infrastructure, enhanced healthcare facilities, and increased awareness, all of which positively influence the diagnosis and treatment of vascular diseases. For example, in June 2023, the Centers for Medicare & Medicaid Services (CMS), a U.S.-based organization that administers major healthcare programs, reported in the National Health Expenditure Projections 2023-2024 that health expenditure growth rates in the United States are expected to be 5% this year and 5.1% the following year. Consequently, rising healthcare expenditure is propelling the vascular stent market forward.
Major companies are strategically partnering with start-ups and mid-sized firms in the vascular stent market to expand their product and service offerings. Such collaborations and partnership agreements enable companies to enhance their existing product portfolios and extend their geographical reach. For instance, in September 2023, The Electrospinning Company, a UK-based manufacturer of advanced biomaterials for implantable tissue-regenerative devices, collaborated with Relisys Medical Devices, an India-based producer of highly innovative cardiovascular medical devices, to develop groundbreaking products that could enhance cardiovascular care and transform patient outcomes. Through this partnership, the Electrospinning Company's Caladrix technology allows for the deposition of a thin, functional polymer coating without the need for sutures, enabling the manufacturing of vascular stents with improved production rates and yields while maintaining efficacy.
In January 2024, Olympus Corporation, a Japan-based company specializing in the development, manufacture, and sale of medical technology and precision instruments, acquired Taewoong Medical Co., Ltd. for $0.370 billion. This acquisition is intended to strengthen Olympus Corporation's gastrointestinal product portfolio, enhance patient outcomes, and broaden its global market presence in the GI medical device sector. Taewoong Medical Co., Ltd., a manufacturing company based in South Korea, produces vascular stents designed to treat narrowed blood vessels and improve circulation.
Major companies operating in the vascular stent market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Cook Medical, W. L. Gore & Associates, Meril Life Sciences, Sahajanand Medical Technologies, Translumina, Lepu Medical Technology, Stentys, Endologix, JOTEC, Hexacath, iVascular, Balton, Opto Circuits
North America was the largest region in the vascular stent market share in 2025. The regions covered in the vascular stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the vascular stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vascular stent market consists of sales of bare metal stents, bioresorbable scaffold systems, and drug-eluting balloons. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vascular Stent Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses vascular stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vascular stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular stent market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.